| Cash and cash equivalents |
313.58M |
| Loans: |
| Loans held for sale, at lower of cost or fair value |
| Loans held for investment, at amortized cost |
| Loans held for investment in consolidated trusts, at amortized cost |
1.04B |
| Allowance for loan losses |
-4.95M |
| Total loans, net of allowance |
4.33B |
| Real estate owned, at lower of cost or fair value |
1.53M |
| Financial derivatives, at fair value |
| Interest receivable |
| Guarantee and commitment fees receivable |
39.66M |
| Deferred tax asset, net |
| Prepaid expenses and other assets |
95.07M |
| Total Assets |
16B |
| Due within one year |
9.3B |
| Due after one year |
4.82B |
| Total notes payable |
| Debt securities of consolidated trusts held by third parties |
1.04B |
| Financial derivatives, at fair value |
| Accrued interest payable |
40.27M |
| Guarantee and commitment obligation |
37.76M |
| Accounts payable and accrued expenses |
| Reserve for losses |
| Total Liabilities |
15.4B |
| Commitments and Contingencies (Note 5) |
0 |
| Series C, par value $1,000 per share, 100,000 shares authorized, 57,578 shares issued and outstanding |
58.33M |
| Common stock: |
| Additional paid-in capital |
118.9M |
| Accumulated other comprehensive income |
13.56M |
| Retained earnings |
252.99M |
| Total Stockholders' Equity |
600.69M |
| Non-controlling interest - preferred stock |
194K |
| Total Equity |
600.88M |
| Total Liabilities and Equity |
16B |
| Common stock: |
| Common stock |
1.03M |
| Common stock: |
| Common stock |
500K |
| Common stock: |
| Common stock |
8.95M |
| Loans: |
| Available-for-sale, at fair value |
3B |
| Trading, at fair value |
0 |
| Total securities |
3B |
| Loans: |
| Available-for-sale, at fair value |
4.94B |
| Loans: |
| Available-for-sale, at fair value |
1.98B |
| Trading, at fair value |
23.49M |
| Total securities |
6.09B |
